Description:
Reference Number:1724
Background
The severity of many diseases such as anxiety, asthma and hypertension varies
with the bodies’ internal clock. There is increasing evidence to show that these
natural rhythms can also affect the bodies responsiveness to drugs and so
optimal treatment of these diseases could be enhanced by delivery of the drug at
the time when clinical signs develop or increase.
Technology
Researchers at the University of Strathclyde have developed a novel platform
oral delivery system that provides optimal controlled drug release profiles
without the need for expensive and time consuming processes. This technology
provides a simple cost-effective platform that can be used to deliver
combinations of drugs to the body at optimal times to maximise therapeutic
benefit.
Key Benefits
- Oral drug delivery platform technology with the unique ability to deliver
drug combinations in complex release patterns
- The delivery device performs independently of gastrointestinal pH to allow
time-specific release
- Streamlined manufacturing process that is readily scaleable
- This delivery device presents the opportunity to aid patient compliance
and has the potential to minimise drug related side effects
Markets and Applications
This is a platform technology and so the market potential of this delivery
system is broad – clinical areas for application of this technology include, but
are not limited to, hypertension, asthma, anxiety, epilepsy, pain, sleep
disorders and infections.
Licensing and Development
The technology is a novel finding that constitutes a patentable invention.
The IP is protected through non-disclosure and contact is welcomed from
organisations interested in developing or exploiting this technology
For further information, please contact Research & Knowledge Exchange
Services:
e: rkes@strath.ac.uk t: 0141 548 3707 f: 0141 552 4409
This project has received assistance from the Proof of Concept Fund managed
by Scottish Enterprise. The Proof of Concept Fund supports the
pre-commercialisation of leading-edge technologies emerging from Scotland's
universities, research institutes and NHS Trusts.